Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study

被引：0

作者：

Strand, Vibeke ^{[1
]}

Tundia, Namita ^{[2
]}

Friedman, Alan ^{[2
]}

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] AbbVie Inc, N Chicago, IL USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

501

引用

页数：2

共 50 条

[1] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
Feist, Eugen
Nasonov, Evgeny
Luggen, Michael
Fatenejad, Saeed
Grishin, Sergey
Samsonov, Mikhail
Fleischmann, Roy
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
[2] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
Kivitz, A.
Wells, A. F.
Vargas, J. Ignacio
Baraf, H. S. B.
Rischmueller, M.
Klaff, J.
Khan, N.
Li, Y.
Carter, K.
Friedman, A.
Durez, P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 620 - 621
[3] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
Alan Kivitz
Alvin F. Wells
Juan I. Vargas
Herbert S. B. Baraf
Maureen Rischmueller
Justin Klaff
Nasser Khan
Yihan Li
Kyle Carter
Alan Friedman
Patrick Durez
Rheumatology and Therapy, 2023, 10 : 901 - 915
[4] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
Kivitz, Alan
Wells, Alvin F.
Vargas, Juan I.
Baraf, Herbert S. B.
Rischmueller, Maureen
Klaff, Justin
Khan, Nasser
Li, Yihan
Carter, Kyle
Friedman, Alan
Durez, Patrick
RHEUMATOLOGY, 2023, 62
[5] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
Kivitz, Alan
Wells, Alvin F. F.
Vargas, Juan I. I.
Baraf, Herbert S. B.
Rischmueller, Maureen
Klaff, Justin
Khan, Nasser
Li, Yihan
Carter, Kyle
Friedman, Alan
Durez, Patrick
RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
[6] Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients - Patient-reported outcomes from multiple controlled and open-label extension studies
Schiff, MH
Yu, EB
Weinblatt, ME
Moreland, LW
Genovese, MC
White, B
Singh, A
Chon, Y
Woolley, JM
DRUGS & AGING, 2006, 23 (02) : 167 - 178
[7] Patient-Reported Benefits of Sarilumab Monotherapy in Adult Patients with Active Rheumatoid Arthritis: Results from an Open-Label Extension Study
Strand, Vibeke
Reaney, Matthew
Mangan, Erin
van Hoogstraten, Hubert
Boklage, Susan
Hu, Chih-Chi
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[8] CLINICAL OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB MONOTHERAPY IN THE OPEN-LABEL LONG-TERM EXTENSION
Fleischmann, R.
Wollenhaupt, J.
Wang, L.
Maniccia, A.
Kwok, K.
Takiya, L.
van Vollenhoven, R.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 259 - 260
[9] EVALUATION OF RESPONSE TO PNEUMOCOCCAL VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB: RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY
Winthrop, K.
Ignacio Vargas, J.
Drescher, E.
Garcia Garcia, C.
Friedman, A.
Enejosa, J.
Khan, N.
Li, Y.
Klaff, J.
Kivitz, A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 486 - 487
[10] Evaluation of Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis Receiving Upadacitinib: Results from a Phase 2 Open-Label Extension Study
Winthrop, Kevin
Vargas, Juan
Drescher, Edit
Garcia, Conrado
Friedman, Alan
Enejosa, Jeffrey
Khan, Nasser
Li, Yihan
Klaff, Justin
Kivitz, Alan
ARTHRITIS & RHEUMATOLOGY, 2020, 72

← 1 2 3 4 5 →